These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9990363

  • 1. A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis.
    Wall AR, Poyner TF, Menday AP.
    Br J Dermatol; 1998 Dec; 139(6):1005-11. PubMed ID: 9990363
    [Abstract] [Full Text] [Related]

  • 2. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, Oranje AP, de Rie MA, de Waard-van der Spek FB, Hol CW, van de Kerkhof PC.
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [Abstract] [Full Text] [Related]

  • 3. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, Damstra R, Oranje AP, de Waard-van der Spek FB, van Neer P, Lijnen RL, Kunkeler AC, van Hees C, Haertlein NG, Hol CW.
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [Abstract] [Full Text] [Related]

  • 4. Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis.
    Monastirli A, Georgiou S, Pasmatzi E, Sakkis T, Badavanis G, Drainas D, Sagriotis A, Tsambaos D.
    Skin Pharmacol Appl Skin Physiol; 2002 Oct; 15(4):246-51. PubMed ID: 12218286
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
    Dutz JP, Lui H.
    Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
    [Abstract] [Full Text] [Related]

  • 6. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis.
    Berth-Jones J, Chu AC, Dodd WA, Ganpule M, Griffiths WA, Haydey RP, Klaber MR, Murray SJ, Rogers S, Jurgensen HJ.
    Br J Dermatol; 1992 Sep; 127(3):266-71. PubMed ID: 1390171
    [Abstract] [Full Text] [Related]

  • 7. Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol.
    Poyner TF, Menday AP, Williams ZV.
    J Eur Acad Dermatol Venereol; 2000 May; 14(3):153-8. PubMed ID: 11032056
    [Abstract] [Full Text] [Related]

  • 8. Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis.
    Ashcroft DM, Po AL, Williams HC, Griffiths CE.
    BMJ; 2000 Apr 08; 320(7240):963-7. PubMed ID: 10753146
    [Abstract] [Full Text] [Related]

  • 9. The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol.
    Hutchinson PE, Marks R, White J.
    Dermatology; 2000 Apr 08; 201(2):139-45. PubMed ID: 11053917
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol. In the treatment of mild to moderate plaque psoriasis.
    Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE.
    Pharmacoeconomics; 2000 Nov 08; 18(5):469-76. PubMed ID: 11151400
    [Abstract] [Full Text] [Related]

  • 11. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis.
    Hofmann UB, Eggert AA, Bröcker EB, Goebeler M.
    Br J Dermatol; 2003 Apr 08; 148(4):779-83. PubMed ID: 12752138
    [Abstract] [Full Text] [Related]

  • 12. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, Andres P.
    J Eur Acad Dermatol Venereol; 2007 Apr 08; 21(4):466-72. PubMed ID: 17373972
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L, Cutler TP, Helander I, Nyfors B, Downes N.
    Br J Dermatol; 1997 Jan 08; 136(1):89-93. PubMed ID: 9039301
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis.
    Van de Kerkhof PC, Green C, Hamberg KJ, Hutchinson PE, Jensen JK, Kidson P, Kragballe K, Larsen FG, Munro CS, Tillman DM.
    Dermatology; 2002 Jan 08; 204(3):214-21. PubMed ID: 12037450
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of calcipotriol ointment (50 micrograms/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis.
    Pinheiro N.
    Br J Clin Pract; 1997 Jan 08; 51(1):16-9. PubMed ID: 9158266
    [Abstract] [Full Text] [Related]

  • 16. Treatment of plaque-type psoriasis with the 308 nm excimer laser in combination with dithranol or calcipotriol.
    Rogalski C, Grunewald S, Schetschorke M, Bodendorf MO, Kauer F, Simon JC, Paasch U.
    Int J Hyperthermia; 2012 Jan 08; 28(2):184-90. PubMed ID: 22335232
    [Abstract] [Full Text] [Related]

  • 17. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC.
    Br J Dermatol; 2004 Sep 08; 151(3):663-8. PubMed ID: 15377355
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun 08; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
    Guenther L, Van de Kerkhof PC, Snellman E, Kragballe K, Chu AC, Tegner E, Garcia-Diez A, Springborg J.
    Br J Dermatol; 2002 Aug 08; 147(2):316-23. PubMed ID: 12174105
    [Abstract] [Full Text] [Related]

  • 20. The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs.
    Jensen M, Groth L, Hølmer G, Hansen HS, Fullerton A.
    Skin Pharmacol Appl Skin Physiol; 2002 Aug 08; 15(6):401-13. PubMed ID: 12476014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.